Page last updated: 2024-11-07

1,2-hexanoylphosphatidylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2-hexanoylphosphatidylcholine: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124160
CHEMBL ID346715
MeSH IDM0100537

Synonyms (10)

Synonym
dihexanoyl-lecithin
2,3-di(hexanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
CHEMBL346715
1,2-hexanoyl-sn-glycero-3-phosphocholine
53892-41-4
1,2-hexanoylphosphatidylcholine
3,5,9-trioxa-4-phosphapentadecan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxohexyl)oxy)-, hydroxide, inner salt, 4-oxide
DTXSID80968679
2,3-bis(hexanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
PD085599
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (43)

Processvia Protein(s)Taxonomy
G2/M transition of mitotic cell cycle1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
signal transduction1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
G protein-coupled receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
glutamate receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
learning1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
memory1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
regulation of G protein-coupled receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cerebral cortex development1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phosphatidylinositol catabolic process1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of insulin secretion1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of interleukin-12 production1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
inositol trisphosphate metabolic process1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
interleukin-12-mediated signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
interleukin-15-mediated signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of embryonic development1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
fat cell differentiation1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of myoblast differentiation1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
negative regulation of DNA-templated transcription1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of DNA-templated transcription1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of JNK cascade1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phosphatidylinositol metabolic process1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
insulin-like growth factor receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of developmental growth1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
activation of meiosis involved in egg activation1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
interleukin-1-mediated signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
regulation of fertilization1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmission1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
regulation of retrograde trans-synaptic signaling by endocanabinoid1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycle1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cellular response to fluoride1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
regulation of establishment of endothelial barrier1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cellular response to vasopressin1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cellular response to ionomycin1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cellular response to glyceraldehyde1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
ligand-gated ion channel signaling pathway1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of acrosome reaction1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
negative regulation of monocyte extravasation1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
positive regulation of CD24 production1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phosphatidylinositol-mediated signaling1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
release of sequestered calcium ion into cytosol1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
phosphatidylinositol phospholipase C activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phospholipase C activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
GTPase activator activity1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
calcium ion binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
protein binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
calmodulin binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
lamin binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
enzyme binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
identical protein binding1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
nucleus1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cytoplasm1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cytosol1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
nuclear speck1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
nuclear membrane1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
extracellular exosome1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
glutamatergic synapse1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
GABA-ergic synapse1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
postsynaptic cytosol1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
chromatin1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
cytoplasm1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
nuclear speck1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID159234Michaelis-Menten constant was calculated for phospholipase C from Bacillus cereus1998Bioorganic & medicinal chemistry letters, Mar-17, Volume: 8, Issue:6
Enzymatic synthesis of a modified phospholipid and its evaluation as a substrate for B. cereus phospholipase C.
AID159236Compound was evaluated for its inhibitory activity against phospholipase C from Bacillus cereus1998Bioorganic & medicinal chemistry letters, Mar-17, Volume: 8, Issue:6
Enzymatic synthesis of a modified phospholipid and its evaluation as a substrate for B. cereus phospholipase C.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (20.00)18.7374
1990's7 (15.56)18.2507
2000's15 (33.33)29.6817
2010's13 (28.89)24.3611
2020's1 (2.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]